Clinical decision support, such as what is offered by Wolters Kluwer, handles the avalanche of information providers and physicians need to stay informed. The information services company has a team of over 7,000 physician editors – specialists in their domain – who comb through evidenced based research and present it in a unified way, said […]
Ninety-one bipartisan members of Congress have joined in objecting to a Centers for Medicare and Medicaid Services proposed rule for minimum staffing levels at nursing homes.
Payers have seen success in improving health outcomes by taking a holistic approach to member interventions, says Leah Dewey, vice president of Cotiviti.
An 11th Circuit panel in Atlanta has upheld a class action settlement in a $2.7 billion antitrust case against the Blue Cross Blue Shield Association, which means benefits will now be distributed to the subscribers who sued Blue Cross more than a decade ago.
Health equity index measures will be used in determining a plan’s bonus payments, says Christie Teigland, Ph.D., vice president of Research Science and Advanced Analytics at Inovalon.
Centene, the largest Medicaid managed care organization in the country, is down over 1 million members since March, according to CFO Drew Asher during the company’s third quarter earnings call on Tuesday.
Having a central repository for consent would promote both interoperability and health equity, says Daniel Stein, president of Stewards of Change Institute.
More than 2 million people would gain healthcare coverage in 2024 if 10 states were to expand Medicaid eligibility, finds a new analysis from the Urban Institute and the Robert Wood Johnson Foundation.
Artificial intelligence has the potential to improve revenue cycle operations, optimize labor through administrative efficiency and lower operating costs, but it comes with the risk of cybersecurity attacks and patient data breaches, according to Moody’s Investors Service.
A handful of independent pharmacies are suing Express Scripts for allegedly signing a three-year deal with pharmacy benefit manager Prime Therapeutics to fix reimbursement rates, a violation of the Sherman Act.